Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetics and bioequivalence of
Risperidone formulations after administration of single doses to normal, healthy subjects
under fasted conditions.